SCHEMBL927012

SCHEMBL927012

CC(=O)Nc1nc(C)c(-c2cncc(NS(=O)(=O)c3ccccc3)n2)s1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 12/20 0.59
PIK3CA P42336 11/20 0.59
PIK3CD O00329 11/20 0.59
PIK3CB P42338 10/20 0.59
AKT1 P31749 1/20 0.52
MTOR P42345 1/20 0.52
ALDH1A1 P00352 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
GAA P10253 2/20 0.47
HSD17B10 Q99714 1/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
KDM4E B2RXH2 2/20 0.46
MAPT P10636 2/20 0.46
HTT P42858 2/20 0.46
NPC1 O15118 1/20 0.46
LMNA P02545 1/20 0.46
RAB9A P51151 1/20 0.46
POLB P06746 1/20 0.46
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL926176 0.87 PIK3CD (0.58) PIK3CGPIK3CAPIK3CDPIK3CBALDH1A1
SCHEMBL926185 0.84 PIK3CG (0.57) PIK3CGPIK3CAPIK3CDPIK3CBALDH1A1
SCHEMBL924849 0.81 PIK3CD (0.61) PIK3CGPIK3CAPIK3CDPIK3CBALDH1A1
SCHEMBL924694 0.80 PIK3CD (0.67) PIK3CGPIK3CAPIK3CDPIK3CB
SCHEMBL5504166 0.80 PIK3CD (0.47) PIK3CGPIK3CAPIK3CDPIK3CBALDH1A1
SCHEMBL925782 0.79 PIK3CD (0.72) PIK3CGPIK3CAPIK3CDPIK3CB
SCHEMBL927884 0.78 PIK3CD (0.60) PIK3CGPIK3CAPIK3CDPIK3CBALDH1A1
SCHEMBL925550 0.77 PIK3CD (0.72) PIK3CGPIK3CAPIK3CDPIK3CBAKT1
SCHEMBL925403 0.74 PIK3CB (0.61) PIK3CGPIK3CAPIK3CDPIK3CB
SCHEMBL926624 0.74 PIK3CD (0.60) PIK3CGPIK3CAPIK3CDPIK3CBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7868188-B2 5-heteroaryl thiazoles and their use as PI3K inhibitors ASTRAZENECA AB (SE) 2011-01-11 US disclosed
EP-1841763-B1 5-HETEROARYL THIAZOLES AND THEIR USE AS PI3K INHIBITORS ASTRAZENECA AB (SE) 2010-06-30 EP disclosed
US-20080132502-A1 5-Heteroaryl Thiazoles And Their Use As PI3K Inhibitors ASTRAZENECA AB (SE) 2008-06-05 US disclosed
CN-101098869-A 5-heteroaryl thiazoles and their use as p13k inhibitors ASTRAZENECA AB (SE) 2008-01-02 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132502-A1 5-Heteroaryl Thiazoles And Their Use As PI3K Inhibitors MTOR, PIK3R5, PIK3CA PIK3CG 16/4885PIK3CA 3/4885PIK3CD 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.